Zoloft and Hypervigilance - a phase IV clinical study of FDA data

Summary:

Hypervigilance is reported as a side effect among people who take Zoloft (sertraline hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Metformin, and have Enterocolitis bacterial.

The phase IV clinical study analyzes which people have Hypervigilance when taking Zoloft. It is created by eHealthMe based on reports of 128,159 people who have side effects when taking Zoloft from the FDA, and is updated regularly.

What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,801 Zoloft users. Check the latest studies of Zoloft.

What is Hypervigilance?

Hypervigilance is found to be associated with 129 drugs and 289 conditions by eHealthMe. Check the latest studies of Hypervigilance.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

128,159 people reported to have side effects when taking Zoloft.
Among them, 16 people (0.01%) have Hypervigilance.

Among these 16 people:

How long have people been on Zoloft when they have Hypervigilance? *

What is the gender of people who have Hypervigilance when taking Zoloft? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Hypervigilance when taking Zoloft? *

What are other drugs people take besides Zoloft? *

What are other side effects people have besides Hypervigilance? *

Fatigue (feeling of tiredness): 4 people, 25.00%
Agitation (state of anxiety or nervous excitement): 4 people, 25.00%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 25.00%
Insomnia (sleeplessness): 4 people, 25.00%
Post-Traumatic Stress Disorder: 3 people, 18.75%
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 3 people, 18.75%
Dyspnea (difficult or laboured breathing): 3 people, 18.75%
Suicidal Ideation: 3 people, 18.75%
Arrhythmias (irregular heartbeat): 3 people, 18.75%
Memory Loss: 3 people, 18.75%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 12.50%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 2 people, 12.50%
Cardiac Failure Congestive: 2 people, 12.50%
Interstitial Lung Disease: 2 people, 12.50%
Cough: 2 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 12.50%
Hypersensitivity: 2 people, 12.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 12.50%
Diabetes: 2 people, 12.50%
Enterocolitis Bacterial: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and have Hypervigilance?

- Check whether Hypervigilance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zoloft:

Zoloft (138,801 reports)

Hypervigilance treatments and more:

Hypervigilance (1,153 reports)

Browse all side effects of Zoloft:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypervigilance:

Hypervigilance (129 drugs)

Browse all the conditions that are associated with Hypervigilance:

Hypervigilance (289 conditions)

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride (the active ingredients of Zoloft) and Zoloft (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.